Abstract Submission :

Submit Abstract

Registration :

Register Now

Become a Sponsor/Exhibitor :

Become a Sponsor

Conference Organizing Committee :

View Committee

Register Now :

Register Now

Conference Program :

Brochure Download

SCIENTIFIC SESSIONS

  • Pharmacology
  • COVID-19
  • Receptors, Drug action and Mechanism
  • Drug metabolism and excretion
  • Drug discovery and development
Read More

IMPORTANT DATES

Abstract Submission
July 11, 2020

Early Bird Registration
July 11, 2020

Register Now

Scientific Committee

Click on the image to view biography

Socrates Egito

Professor, Iowa University,USA

Professor Socrates Egito received his PhD in 1994 in Paris (France) at the Universite de Paris XI and spent two years as Visitor Professor at the University of Georgia, USA, in 2001 and at the University of Florida, in 2011. Actually, he is in a sabbatical year at The University of Iowa. He joined the Department of Pharmacy at the Federal University of Rio Grande do Norte (UFRN), Brazil, in 1995. He became Professor on Pharmaceutics at the UFRN in 2012 and Director of the LaSiD (Laboratory of Dispersed Systems) since 1996. 

Jelena Hélène Cvejic

Professor, University of Novi Sad, Serbia. Director of Translational Science at Accelsiors

Prof. Jelena Helene Cvejic has more than 20 years of Academic experience focused on biologically active compounds - analysis, use, influence on human health; and more than 10 years of Clinical Research experience including Quality Assurance, Line Management and Business Development. She is a Professor at the University of Novi Sad, Serbia (Faculty of Medicine, Department of Pharmacy) and Director of Translational Science at Accelsiors CRO. She is also a Board Member of Pharmabiotics Research Institute and a Scientific Advisor of ILSI Europe Health Benefits Assessment of Foods task force. In the frame of Clinical Research Prof. Cvejic manages cross-functional business development and research teams to execute strategically implemented programs.
  She is a co-author of more than 50 peer-review scientific publications (articles and book chapters) and reviewer for more than 20 indexed scientific journals, also participating in different international collaborations (eg. Sorbonne University, Scientific Centre of Monaco), research projects (eg.H2020-ERA; H2020-MSCA-RISE) and conferences. She is responsible for teaching several subjects including Instrumental Pharmaceutical Analysis, Analysis of Drugs, Clinical Trials, Stability of Drugs, and Selected Biologically Active Food Ingredients.

Zafer Guney

Professor, Gazi University, Turkey

Prof. Zafer Guney graduated from Ankara University School of Medicine in 1992. He was specialized in Medical Pharmacology in 1997 from Gazi University School of Medicine. Currently he is a professor in department of Pharmacology and Translational Medicne at Gazi University. He is a member of Biyoteg TUBITAK & The Ethics Committee of Zekai Tahir Burak Hospital Ankara.

Dr. Zafer is the owner of the RD Drug Consultancy Ltd., in Ankara. He is also the president of the Biotechnological Drugs Society (BIYILDER).

 

Danxin Wang

Associate Professor, University of Florida

 Danxin Wang earned her M.D degree at Fudan University Medical School, Shanghai China and Ph.D. at Institute of Pharmacology and Toxicology Beijing, China. Currently, she is an Associate Professor in Department of Pharmacotherapy and Translational Research at University of Florida. She has published over 70 research papers and has several United Sate Patent Applications. Her research interest is to discover pharmacogenetic/pharmacogenomics biomarkers for personalized drug therapy, focusing on understanding the genetic, epigenetic and non-genetic factors determining inter-person variability in drug metabolism.

Christopher J. Soares

CEO/Founder, AcheRx, USA.

Chris Soares is the Founder and CEO of AcheRx a biotechnology company developing peptide therapeutics for migraine, neuropathic pain, and neurodegenerative diseases. A lead candidate for the acute treatment of migraine is projected to advance to the clinic in Q2 2020. We are also developing a slow-release formulation to enable once-weekly dosing and investigating nasal and oral delivery options. Chris has previously held senior R&D positions at Avryll Therapeutics where he investigated the formulation of a gene therapeutic and at Amylin Pharmaceuticals where he led groups that resulted in a number of clinical candidates. Dr. Soares’ academic background includes a Ph.D. in Organic Chemistry from the University of California (Davis) and postdoctoral research at The Scripps Research Institute (La Jolla, California) in the laboratories of Prof. Reza Ghadiri where we designed three- and four-helix bundles via metal complexation with the goal of designing artificial proteins.

Rasha Moustafa Youssef

Professor, Alexandria University, Egypt.

Prof. Rasha Moustafa Youssef is a Professor of Pharmaceutical Analytical Chemistry and Quality Control at the Faculty of Pharmacy, Alexandria University, Egypt. She is an Editorial Board Member of International Journal of Environmental Research and Development (IJERD); WORLD JOURNAL of PHARMACY AND PHARMACEUTICAL SCIENCE (WJPPS) and Journal of Pharmacovigilance”.

Currently she is also serving as an Associate Editor of “World Research Journal of analytical Chemistry” and Editorial Review Board of “Journal of American Academic Research (JAAR)”.

She was also the scientific Committee Member for several conferences like International Conference on Pharmaceutical and Healthcare Science (PHS) 2019 and Program Technical Committee Member of 3rd Science Conference of Drug Discovery and Development (3rd SCDDD).

Prof. Rasha also served as a reviewer for highly ranked international journals specialized in analytical chemistry and its applications (e.g.Talanta, Spectrochimica Acta, Pharmaceutica Analytica Acta, Spectroscopy-Biomedical Application, African Journal of pharmacy and pharmacology and Chem Ind. Chem. Eng. Q.).

 

Omnia Ismaiel

Senior Research Scientist, Pharmaceutical Product Development PPD,USA

Dr. Omnia Ismaiel is a Senior Research Scientist at PPD (Pharmaceutical Product Development), USA and also serves as an Associate Professor of Pharmaceutical Analytical Chemistry at Zagazig University, Egypt and graduate affiliate professor at Virginia Commonwealth University, USA. She has more than 13 years of experience in the field of Bio analytics; Pharmaceutical Analysis & Analytical Chemistry. She is a supervisor/mentor for several PhD and master degree students.

Currently Prof. Omnia is also serving as Editor-in-Chief of reviews in Separation Science Journal. She was the co-author of more than 50 peer reviewed scientific publications (articles; journals & posters) and Reviewer for more than 10 high impact peer-reviewed journals. She was an invited speaker at several local/International conferences.
Dr. Omnia Ismaiel earned her MSc degree in Pharmaceutical Analytical Chemistry from Zagazig University and PhD from Virginia Common Wealth University/Zagazig University, channel scholarship.

 

 

 

About Conference


Welcome to pharma conference 2020!

"Note: With due regard to the pandemic CORONAVIRUS/COVID-19 outbreak worldwide; our management has decided to run an online web conference rather than an onsite event and moved the dates from July 22-24, 2020 to September 08-10, 2020 which was previously scheduled in Amsterdam, Netherlands."

 The decision has been taken in the interest of public safety and to help prevent the spread of the virus.

 

It is with an immense pleasure and a great honor, we would like to welcome you all to the virtual on-line or Web Conference on  Pharmaceutics, Pharmacology and Drug Delivery Systems to be held during September 08-10, 2020.

The conference is hosted by Linkin Science. These conferences are well crafted and designed by a team of skilled experts. Our conferences are vast expanded into Medical, life sciences, health care, Engineering and other social sciences. Each conference, summit or executive briefing is tailored to the sector, topic and audience need. Our event structure varies depending on issue and market requirements featuring Keynote presentations, Oral talks, Poster presentations, Young research forum, Exhibitions, roundtables and variable formats. Our mission is to bring the researchers on a common platform and provide opportunity for them to interact. This scientific networking helps for the betterment of science by exchanging the ideas in a broader way. Magnifying Scientific Knowledge by Sharing the research and ideas. We believe in accelerating the possibilities of novel discoveries and enhancement in scientific research, by connecting scientific community for knowledge sharing. Join us to redefine and explore new research, to provide a credible source to barter ideas for scientific studies besides transforming the true outcomes of a distinct scientific discovery and grab the attention for rare emerging technologies.

Benefits:

Join your peers around the world focused on learning about Pharmaceutics, Pharmacology and Drug Delivery Systems, which is your best opportunity to reach the largest gathering of participants from the Pharmaceutics community, conduct demonstrations, distribute research information, meet with current and potential professionals who make a splash with new research works, and receive recognition at this 3-day event. World-renowned speakers who include CEO’S and Company Directors, Professors, Researchers, Pharmacologists, Clinical Pharmacists, Pharmacy Associates and Society Members will be taking part at this reputed conference.

Target Audience:

Students, Scientists and Faculty of Pharmaceutical Universities
Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
Business Entrepreneurs, Training Institutes, Software developing companies
Directors, CEO’s of Organizations
Scholars from Pharmacology, Pharmaceutical, Toxicology backgrounds
Drug Delivery Technology Manufacturers
Business Development Managers
Distributors and Suppliers of Drug Delivery Technologies
Students, Professors, Researchers, and Faculty of Pharmacology & Pharmaceutical Sciences from Universities and Medical Colleges
Researchers from Pharmaceutical Companies, Pharmacy & Pharmacology Associations and Societies
Health professionals
Pharmacists, Pharmacologists, & Toxicologists
Business development professionals, Consultants, Pharma, and  Toxicology Testing service providers
Quality control specialists
Graduates and post graduates in industrial pharmacy
Medical Devices Manufacturing Companies, CROData Management Companies.
Pharmaceutical legislators and regulators Toxicology Testing Companies & Organizations

Scientific Sessions


Pharmacology:

Pharmacology is a part of Biology which is concerned with the Drug action studies. Pharmacology is classified into different types. Clinical pharmacology is a branch of Pharmacology related to drugs and their clinical use. Clinical Pharmacology is the most complete, easiest-to-use and most dependable drug information solution available today. Neuropharmacology is the study of how drugs affect the function of Nervous system. Psychopharmacology is the study of the use of medications in treating mental disorders. Cardiovascular pharmacology is the science which evaluates the drugs used in the treatment of Cardiovascular Disorders. Systems pharmacology is an application of system biology principles to the field of Pharmacology. Toxicology is a branch related to Biology, Medicine and Chemistry concerned with the adverse effects of Chemicals on Living organisms. Theoretical pharmacology uses techniques of computational quantum chemistry and the method of Molecular Mechanics. Environmental pharmacology is a branch of pharmacology that deals entry of chemicals or drugs into the environment after elimination from humans and animals as post-therapy. Dental pharmacology is the study of drugs of the oral cavity. 

Targeted Drug Delivery:

Targeted Drug Delivery is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs and tissues or cells. Active targeting involves attaching to the drug delivery system something like an antibody, or carrier protein or a ligand which will allow it to go and meet and complex with the cell having the receptor for the attachment. Passive targeting or physical targeting involves the preparation of a drug carrier complex that can avoid the elimination due to body defense mechanisms like metabolism, excretion and opsonisation followed by phagocytosis. There are different types of drug delivery vehicles, such as polymeric micelles, liposomes, lipoprotein-based drug carriers, nano-particle drug carriers, dendrimers, etc. An ideal drug delivery vehicle must be non-toxic, biocompatible, non-immunogenic, biodegradable and must avoid recognition by the host's defense mechanisms.

Receptors, Drug action and Mechanism:

A receptor is a protein molecule that receives chemical signals from outside a cell. The structures of receptors are very diverse and can broadly be classified into L (Ionic receptors), G protein couple receptors (metabotropic), Kinase-linked and related receptors, Nuclear receptors. Drugs interact with receptors by bonding at specific binding sites. Most receptors are made up of proteins, and the drugs can therefore interact with the amino acids to change the conformation of the receptor proteins. Drugs interact with receptors by bonding at specific binding sites. Most receptors are made up of proteins, and the drugs can therefore interact with the amino acids to change the conformation of the receptor proteins. Drug mechanism of action is determined by Microscopy-based methods, direct biochemical method, Computation inference methods. When talking about the shape of molecules, biochemists are mainly concerned with the three-dimensional conformation of drug molecules. There are many isomers of a particular drug, and each one will have its own effects. Differences in isomer affect not only what the drug activates, but also changes the potency of each drug.

Drug metabolism and excretion:

The metabolism of drugs and other xenobiotics into more hydrophilic metabolites is essential for the elimination of these compounds from the body and termination of their biological activity. The liver is the principal site of drug metabolism. Although metabolism typically inactivates drugs, some drug metabolites are pharmacologically active—sometimes even more so than the parent compound. Drug Metabolism is concerned with Permeability barriers and detoxification, Phases of detoxification, Endogenous toxins and the factors that affect drug metabolism. Excretion is a process whereby drugs are transferred from the internal to the external environment. Despite the reduction in activity that occurs as a drug leaves its site of action, it may remain in the body for a considerable period, especially if it is strongly bound to tissue components. Excretion, along with metabolism and tissue redistribution, is important in determining both the duration of drug action and the rate of drug elimination. Principal organs involved Kidneys, Lungs, Biliary system, Intestines, Saliva, and Milk.

Drug discovery and development:

The idea that the effect of a drug in the human body is mediated by specific interactions of the drug molecule with biological macromolecules, (proteins or nucleic acids in most cases) led scientists to the conclusion that individual chemicals are required for the biological activity of the drug. The first step in the drug discovery process is to identify a suitable target. This is a molecule or a protein receptor that is specifically associated with a disease condition or pathology. For this purpose, it is important to understand how the disease occurs at the molecular, cellular, and genetic levels. The drug development phase involves rigorous testing and optimization of the selected compounds to identify the lead structure or candidate drug’ which might be the most effective. Testing required by the health authorities is done in cells (in vitro) and in animals (in vivo) to study metabolism safety, toxicity, dosage, and efficacy.

Pharmacokinetics and Pharmacodynamics:

Pharmacokinetics is the quantitative study of drug movement in, through and out of the body. Intensity of effect is related to concentration of the drug at the site of action, which depends on its pharmacokinetic properties and these properties of particular drug is important to determine the route of administration, dose, onset of action, peak action time, duration of action and frequency of dosing. Pharmacodynamics is the branch of pharmacology concerned with the action of drugs on the body or on microorganisms within or on the body.

Pharmacoepidemiology and Pharmacovigilance:

Pharmacoepidemiology is the study of drug efficacy, toxicity and patterns of use in large populations. Thus, pharmacoepidemiology can be called a bridge science spanning both pharmacology and epidemiology. Pharmacoepidemiology sometimes also involves the conduct and evaluation of programmatic efforts to improve medication use on a population basis.  Pharmacovigilance is a type of continual monitoring for unwanted effects and other safety-related aspects of drugs that are already on the market. Pharmacovigilance has been defined by the World Health Organisation as “The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problem”

Pharmacogenetics and Genomics:

Pharmacogenetics is the study of how the actions of and reactions to drugs vary with the patient's genes. Pharmacogenetics studies the genetic variation between people underlying differential response to drugs. Genes determine the make-up of all the body's proteins, and as medicines travel through the body they interact with many of these proteins. This relatively new field allows us to combine pharmacology and genomics to develop effective and safe medication dosages which are specific to an individual’s DNA makeup. 

Pharmaceutical engineering:

Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry. A pharmaceutical engineer is a specialized chemical engineer who focuses on creating new pharmaceutical drugs and improving upon existing products and manufacturing processes. Pharmaceutical engineering is subject to various regulations in different countries, and pharmaceutical engineers must ensure they maintain personal and environmental safety at all times.

Pharmaceutical formulation:

Pharmaceutical formulation is a process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. The pharmaceutical formulations process involves the entire process of a how a drug is developed and how it is finally accepted by the patient. The drug form varies by the route of administration. Like capsules , tablets and pills etc. Parenteral formulations also called injectable formulations and are used with intravenous, subcutaneous, intramuscular, and intra-articular administration. In the pharmaceutical drug formulations, the different physical, chemical, and mechanical properties of a drug are considered so as to know what other ingredients should be used in the preparation.

Pharmaceutical microbiology:

Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals like minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial by-products like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile. The most important contribution of microbiology to the pharmaceutical industry is the development of antibiotics. Apart from drugs and bio products development, microbiology contributes towards quality control of a pharmaceutical laboratory. Prevention of microbial contamination of drugs, injectables, eye drops, nasal solutions and inhalation products is undertaken following pharmacopeial guidelines.

Pharmacognosy:

Pharmacognosy is the study of medicines or crude drugs produced from natural sources such as plants, microbes, and animals. It includes analysis of their biological, chemical, biochemical, and physical properties. It includes the study of various disciples such as ethnobotony, ethnopharmacology, Phytotherapy, Phytochemistry, Zoopharmacognosy, Marine pharmacognosy etc. The part of pharmacognosy focusing on the use of crude extracts or semi-pure mixtures originating from nature, namely phytotherapy, is probably the best known and also the most debated area in pharmacognosy. 

Medicinal Chemistry:

Medicinal chemistry is the chemistry discipline concerned with the design, development and synthesis of pharmaceutical drugs. The discipline combines expertise from chemistry and pharmacology to identify, develop and synthesize chemical agents that have a therapeutic use and to evaluate the properties of existing drugs.

Biopharmaceutics:

Biopharmaceutics is the study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action, including coconstituents and mode of manufacture. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biopharmaceuticals are majorly extracted from living systems (Whole blood and other blood components, Organs and tissue transplants, Stem cell therapy, Antibodies for passive immunization, Human breast milk, Fecal microbiota, Human reproductive cells) produced by recombinant DNA (Body’s own signelling proteins like Erythropoetin, Human insulin etc and other Monoclonal antibodies and fusion proteins) Major kinds of biopharmaceuticals include Blood factors, Thrombolytic agents, Hormones, Haematopoietic growth factors, Interferons, Interleukin-based products, Vaccines, Monoclonal antibodies etc.

Pharmacotherapy:

Pharmacotherapy is the Study of the use and effects produced by drugs on patients as well as the treatment of illnesses by administering drugs. Pharmacists are experts in pharmacotherapy and are responsible for ensuring the safe, appropriate, and economical use of pharmaceutical drugs. The skills required to function as a pharmacist require knowledge, training and experience in biomedical, pharmaceutical and clinical sciences.

 

Process Validation, Qualification and Good Manufacturing Practices:

Validation is establishing documented evidence which provides a high degree of assurance that a specific process or equipment will consistently produce a product or result meeting its pre-determined specification and quality attributes. Validation is a key process for effective Quality Assurance. A GMP is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production from the starting materials, premises and equipment to the training and personal hygiene of staff. 

Hospital pharmacy:

Hospital Pharmacy is a department or service in a hospital, responsible for the supply of medications to hospital wards as well as ambulatory patients, The department is headed by professionally competent, legally qualified pharmacist who directly supervises and ensures the correct dispensing, compounding, and distribution of medication to in and out-patients. The major goals include providing the benefits of a qualified hospital pharmacist to patients and health care institutions, to the allied health professions, and to the profession of pharmacy, To assist in providing an adequate supply of such qualified hospital pharmacists, To assure a high quality of professional practice through the establishment and maintenance of standards of professional ethics, education, and attainments and through the promotion of economic welfare, To promote research in hospital pharmacy practices and in the pharmaceutical sciences in general, To disseminate pharmaceutical knowledge by providing for interchange of information among hospital pharmacists and with members of allied specialties and professions.

Pharmaceutical Management:

Pharmaceutical Management is a division of management that deals with chemical and health sciences and ensures the effective and safe use of pharmaceutical drugs.  Pharmaceutical Management integrates business strategy with science and technology and the unique perspective of the industry.

Market Analysis


Market Analysis:

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

Europe is one such region which encompasses the major share of the Pharmacology and Toxicology research. Spain being one of the most advanced European economies is bound to hold the chief share in Europe’s Pharmacology market. Further as EU expands the research, export and trading relations are bound to enhance.

Market Analysis of Global Pharmaceutical Industries

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

According to the QuintilesIMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Major Pharmacology Associations around the Globe

  • American Academy of Veterinary Pharmacology and Therapeutics
  • American Board of Clinical Pharmacology
  • Argentine Society for Experimental Pharmacology
  • Association of Pharmacologists of Ukraine
  • Australian Physiological and Pharmacological Society
  • British Association for Psychopharmacology
  • Colombian Association of Pharmacology

Benefits of Using Web Conferencing


Saves on Travel Cost and Time 

Prior to web conferencing in business, if you wanted to bring together a sales team spread out across the country or meet face-to-face with a client who lives out of town, you (or they) had to travel. Not only can travel be expensive but it also takes time. Web conferencing saves businesses time and money. Within a few minutes, meeting attendees can log on to the meeting without wasting time at the airport or spending money on a ticket. Even if the business pays for a web conferencing service, it is typically less expensive than travel expenses. 

Increases Work Efficiency

Scheduling meetings typically takes more work than simply inviting or mandating attendees. If you’re the host, you have to book a conference room, plan the agenda and in some cases order catering and more. Web conferencing eliminates all of these booking needs, which means putting together a meeting is faster and easier than face-to-face meetings.

Flexible

Web conferencing provides more flexibility. Typically, you send an email invitation or pick up the phone to alert attendees of the web conference. Within minutes, attendees can log into the web conference system and the meeting starts.

Increases Engagement

Web conferencing allows the host to upload slides and other graphics, too. With the audio and visual components of holding a web conference, the format helps to increase the engagement level of the conference attendees.

Eliminates Geographic Barriers

Since anyone with an Internet connection and computer can attend a web conference, web conferencing eliminates geographic barriers of all kinds. Web conferencing opens up possibilities for communication with employees and customers worldwide.

Scientific Sessions

Abstract Submission : July 11, 2020

Early Bird Registration : July 11, 2020

  • Pharmacology
  • COVID-19
  • Receptors, Drug action and Mechanism
  • Drug metabolism and excretion
  • Drug discovery and development
  • Pharmacokinetics and Pharmacodynamics
  • Pharmacoepidemiology and Pharmacovigilance
  • Pharmacogenetics and Genomics
  • Pharmaceutical engineering
  • Pharmaceutical formulation
  • Pharmaceutical Microbiology
  • Pharmacognosy
  • Medicinal Chemistry
  • Biopharmaceutics
  • Pharmacotherapy
  • Clinical Pharmacy
  • Hospital pharmacy
  • Pharmaceutical Management
  • Process Validation, Qualification and Good Manufacturing Practices
  • Pharmaceutical Chemsitry
  • Pharmaceutical Analysis
  • Pharmaceutical drugs

Registration Categories

Abstract Submission : July 11, 2020

Early Bird Registration : July 11, 2020

Awards

Participants desiring to be considered for one of these awards need to specify their interest after their submission of the required abstract. Selected participants will receive felicitation certificates under three categories:

  1. Outstanding Submitted Abstract
  2. Best Research of the conference as evaluated by the Scientific Committee
  3. Young Researcher Award under YRF category to encourage budding scientists/ researcher.


Decisions will be made based on evaluation of the submitted abstract by the Scientific Committee. The decision made by the Scienctific Committe would be final. We want you to grab this opportunity and participate in the conference...!

Past Conference Report

Past Conference Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Global Pharma Meet 2018 Conference the best ever!

Global Pharma Meet, hosted by the Linkin Science was held during April 02-03, 2018 at Grand Excelsior Hotel Bur Dubai in Dubai based on the theme “Comprehensive Global Research in Fostering Innovative Pharmaceutical Drug Analysis" which got magnificent response. With the support and guidance of Scientific Committee Members and amazing presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Pharma has made this event a grand success. With this success, we would like to welcome you once again to our 2nd International Conference on Pharmaceutics, Pharmacology and Drug Delivery Systems to be held during September 08-10, 2020.

<
Media Partners
No Image
Need Help ? Write to Us